用于治疗喘的生物制剂的副作用
Andrea Sitek1, Sergio E Chiarella2, Thanai Pongdee2
1Division of Allergy, Clinical Immunology and Rheumatology, University of Kansas Medical Center, 4000 Cambridge Street, MS 2026, 5026 Wescoe, Kansas City, KS 66160, USA.
Therapeutic advances in respiratory disease
|March 18, 2025
概括
本综述详细介绍了FDA批准的用于喘管理的生物药物相关的风险,包括过敏,感染和恶性瘤. 它旨在帮助医疗服务提供者为患者提供有关这些重要疗法的潜在不良影响的建议.
科学领域:
- 肺病学和过敏症的研究
- 药理学和治疗学 药理学和治疗学
背景情况:
- 生物药物越来越多地用于中度至重度喘管理.
- 了解这些新型疗法的安全性是临床实践的关键.
研究的目的:
- 综合审查目前FDA批准的喘生物药物的风险和不良影响.
- 为临床医生提供患者咨询和不良事件识别的基本信息.
主要方法:
- 对特定生物制品报告的风险和不良影响进行系统审查.
- 专注于过敏反应,感染,恶性瘤,心血管疾病和eosinophilia.
- 包括关于怀孕期间使用疫苗和生物制剂的数据.
主要成果:
- 详细讨论与奥马利祖马布,本拉利祖马布,杜皮卢马布,梅波利祖马布,雷斯利祖马布和特泽佩卢马布相关的已知不良事件.
- 分析特定的安全问题,包括过敏,感染风险和恶性瘤的可能性.
- 考虑心血管风险,乙,疫苗相互作用和怀孕安全数据.
结论:
- 提供者必须了解喘生物制剂的综合风险概况.
- 关于潜在的不良影响的知情患者咨询对于安全有效的治疗至关重要.
- 在接受喘生物治疗的患者中,对不良事件的持续监测至关重要.
相关概念视频
Antiasthma Drugs: β2-Adrenoceptor Agonists
201
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
201
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
204
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
204
Antiasthma Drugs: Leukotriene Modifiers
208
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
208
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
183
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
183
Drugs Used in Lower Respiratory Disorders: Overview
329
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
329
Asthma-III: Symptoms and Complications
2.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.4K


